| Title : Neurotherapeutic effects of Vutiglabridin as a Paraoxonase-2 modulator in preclinical models of Parkinson's disease - An_2025_Mol.Neurodegener_20_110 |
| Author(s) : An H , Kang S , Shin J , Kim P , Kim S , Im S , Kim JH , Lee KW , Kim DH , Park JH , Park MH , Lee J , Park SK , Kim KP , Lee HM , Lee JH , Choi LS , Jeon HJ , Kim SY , Hwang IY , Bhalla M , Won W , Park HS , Yoo SK , Lee BD , Lee CJ , Pak YK |
| Ref : Mol Neurodegener , 20 :110 , 2025 |
| Abstract : |
| PubMedSearch : An_2025_Mol.Neurodegener_20_110 |
| PubMedID: 41107874 |
| Title : Neurotherapeutic effects of Vutiglabridin as a Paraoxonase-2 modulator in preclinical models of Parkinson's disease - An_2025_Mol.Neurodegener_20_110 |
| Author(s) : An H , Kang S , Shin J , Kim P , Kim S , Im S , Kim JH , Lee KW , Kim DH , Park JH , Park MH , Lee J , Park SK , Kim KP , Lee HM , Lee JH , Choi LS , Jeon HJ , Kim SY , Hwang IY , Bhalla M , Won W , Park HS , Yoo SK , Lee BD , Lee CJ , Pak YK |
| Ref : Mol Neurodegener , 20 :110 , 2025 |
| Abstract : |
| PubMedSearch : An_2025_Mol.Neurodegener_20_110 |
| PubMedID: 41107874 |
| Title : Neurotherapeutic effects of Vutiglabridin as a Paraoxonase-2 modulator in preclinical models of Parkinson's disease - An_2025_Mol.Neurodegener_20_110 |
| Author(s) : An H , Kang S , Shin J , Kim P , Kim S , Im S , Kim JH , Lee KW , Kim DH , Park JH , Park MH , Lee J , Park SK , Kim KP , Lee HM , Lee JH , Choi LS , Jeon HJ , Kim SY , Hwang IY , Bhalla M , Won W , Park HS , Yoo SK , Lee BD , Lee CJ , Pak YK |
| Ref : Mol Neurodegener , 20 :110 , 2025 |
| Abstract : |
| PubMedSearch : An_2025_Mol.Neurodegener_20_110 |
| PubMedID: 41107874 |
| Title : Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study - Lim_2008_Clin.Ther_30_1817 |
| Author(s) : Lim KS , Kim JR , Choi YJ , Shin KH , Kim KP , Hong JH , Cho JY , Shin HS , Yu KS , Shin SG , Kwon OH , Hwang DM , Kim JA , Jang IJ |
| Ref : Clin Ther , 30 :1817 , 2008 |
| Abstract : |
| PubMedSearch : Lim_2008_Clin.Ther_30_1817 |
| PubMedID: 19014837 |
| Title : Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study - Lim_2008_Clin.Ther_30_1817 |
| Author(s) : Lim KS , Kim JR , Choi YJ , Shin KH , Kim KP , Hong JH , Cho JY , Shin HS , Yu KS , Shin SG , Kwon OH , Hwang DM , Kim JA , Jang IJ |
| Ref : Clin Ther , 30 :1817 , 2008 |
| Abstract : |
| PubMedSearch : Lim_2008_Clin.Ther_30_1817 |
| PubMedID: 19014837 |
| Title : Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study - Lim_2008_Clin.Ther_30_1817 |
| Author(s) : Lim KS , Kim JR , Choi YJ , Shin KH , Kim KP , Hong JH , Cho JY , Shin HS , Yu KS , Shin SG , Kwon OH , Hwang DM , Kim JA , Jang IJ |
| Ref : Clin Ther , 30 :1817 , 2008 |
| Abstract : |
| PubMedSearch : Lim_2008_Clin.Ther_30_1817 |
| PubMedID: 19014837 |